These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37208258)

  • 21. [Application of the PCR number of cycle threshold value (Ct) in COVID-19].
    Serrano-Cumplido A; Ruiz Garcia A; Segura-Fragoso A; Olmo-Quintana V; Micó Pérez RM; Barquilla-García A; Morán-Bayón A
    Semergen; 2021; 47(5):337-341. PubMed ID: 34154912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
    To KK; Tsang OT; Leung WS; Tam AR; Wu TC; Lung DC; Yip CC; Cai JP; Chan JM; Chik TS; Lau DP; Choi CY; Chen LL; Chan WM; Chan KH; Ip JD; Ng AC; Poon RW; Luo CT; Cheng VC; Chan JF; Hung IF; Chen Z; Chen H; Yuen KY
    Lancet Infect Dis; 2020 May; 20(5):565-574. PubMed ID: 32213337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region.
    Markewitz R; Torge A; Wandinger KP; Pauli D; Dargvainiene J; Franke A; Bujanda L; Marimón JM; Banales JM; Gutierrez-Stampa MA; Nafría B; Junker R
    Int J Infect Dis; 2021 Sep; 110():114-122. PubMed ID: 34273511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trajectories of the SARS-CoV-2 RNA load in patients with hematological malignancy.
    Mitsuyuki S; Nishikubo M; Shimomura Y; Ohyama Y; Maruoka H; Nasu S; Kubo T; Suzuki Y; Okada N; Nakagawa D; Kamijo K; Yamamoto R; Nagai Y; Hiramoto N; Yoshioka S; Yonetani N; Hasegawa K; Kuroda H; Hasuike T; Doi A; Kondo T; Ishikawa T
    Eur J Haematol; 2023 Jul; 111(1):57-62. PubMed ID: 36965014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors associated with SARS-CoV-2 pneumonia in the pediatric population.
    Moreno-Noguez M; Rivas-Ruiz R; Roy-García IA; Pacheco-Rosas DO; Moreno-Espinosa S; Flores-Pulido AA
    Bol Med Hosp Infant Mex; 2021; 78(4):251-258. PubMed ID: 34351892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral RNA Load in Symptomatic and Asymptomatic COVID-19 Omicron Variant-Positive Patients.
    Wu Q; Shi L; Li H; Huang S; Li H; Li L; Han J; Wu Q; Pei Z
    Can Respir J; 2022; 2022():5460400. PubMed ID: 36072643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling RT-qPCR cycle-threshold using digital PCR data for implementing SARS-CoV-2 viral load studies.
    Gentilini F; Turba ME; Taddei F; Gritti T; Fantini M; Dirani G; Sambri V
    PLoS One; 2021; 16(12):e0260884. PubMed ID: 34928966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance.
    Blairon L; Cupaiolo R; Thomas I; Piteüs S; Wilmet A; Beukinga I; Tré-Hardy M
    J Med Virol; 2021 Oct; 93(10):5783-5788. PubMed ID: 34050945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [SARS-COV-2 infection in patients with hematological malignancies and transplants].
    Herrera F; Bues F; Rojas R; Temporiti E; Videla C; Dupont J; Bonvehí P
    Medicina (B Aires); 2021; 81(3):396-400. PubMed ID: 34137699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid diagnosis of SARS-CoV-2 pneumonia on lower respiratory tract specimens.
    De Pace V; Caligiuri P; Ricucci V; Nigro N; Galano B; Visconti V; Da Rin G; Bruzzone B
    BMC Infect Dis; 2021 Sep; 21(1):926. PubMed ID: 34493222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients.
    Hirotsu Y; Maejima M; Shibusawa M; Nagakubo Y; Hosaka K; Amemiya K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Yagi S; Kojima S; Omata M
    Int J Infect Dis; 2020 Oct; 99():397-402. PubMed ID: 32800855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients.
    Yu F; Yan L; Wang N; Yang S; Wang L; Tang Y; Gao G; Wang S; Ma C; Xie R; Wang F; Tan C; Zhu L; Guo Y; Zhang F
    Clin Infect Dis; 2020 Jul; 71(15):793-798. PubMed ID: 32221523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiological Correlates of Polymerase Chain Reaction Cycle Threshold Values in the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Salvatore PP; Dawson P; Wadhwa A; Rabold EM; Buono S; Dietrich EA; Reses HE; Vuong J; Pawloski L; Dasu T; Bhattacharyya S; Pevzner E; Hall AJ; Tate JE; Kirking HL
    Clin Infect Dis; 2021 Jun; 72(11):e761-e767. PubMed ID: 32986120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting.
    Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S
    Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
    Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
    Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients.
    Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spatial and temporal distribution of SARS-CoV-2 from the built environment of COVID-19 patient rooms: A multicentre prospective study.
    Fralick M; Burella M; Hinz A; Mejbel HS; Guttman DS; Xing L; Moggridge J; Lapp J; Wong A; Nott C; Harris-Linton N; Kassen R; MacFadden DR
    PLoS One; 2023; 18(3):e0282489. PubMed ID: 36913370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-COV-2 viral load in tears of patients with COVID-19 in the early symptomatic stages: comparison of two different tear sampling methods.
    Sonmez A; Aydın Kurna S; Aslan FG; Kaplan FB; Açıkalın B; Eker P
    Int Ophthalmol; 2022 Aug; 42(8):2425-2438. PubMed ID: 35179659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series.
    Boeckel GR; Hölscher SD; Bürger C; Jacob T; Krekeler C; Shumilov E; Reicherts C; Bleckmann A; Lenz G; Vollenberg R; Tepasse PR
    Curr Oncol; 2022 Mar; 29(4):2312-2325. PubMed ID: 35448162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.